Skip to content
value.today

Pfizer Inc. vs Samumed

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

Market cap history

$0 M$84.4 B$168.9 B$253.3 B$337.8 B2020202120222023202420252026
● Pfizer Inc.● Samumed

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$25B$51B$76B$101B201720182019202020212022202320242025Pfizer Inc. $63B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasurePfizer Inc.
PFE · #126 in the world
Samumed
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryPharmaceutical—
Founded18492008
Size
Market cap$170.7 B—
Revenue$62.6 B—
Net income$7.8 B—
Employees75,000—
Valuation
P/E ratio42.3×—
Price to sales2.7×—
Price to book2.0×—
Free cash flow yield5.3%—
Profitability
Gross margin74.3%—
Net margin12.4%—
Return on equity8.9%—
Growth
Revenue growth-1.6%—
Revenue growth, 3 years a year-14.8%—
Earnings per share growth-3.5%—
Financial strength
Debt to equity0.7×—
Cash
Free cash flow margin14.5%—
Strength scores
Piotroski F-score5 of 9—
Altman Z-score zone——
Data as ofMarket cap Oct 2026; ratios FY2025Market cap —

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Sources#

Every figure on this page comes from these, with the date shown next to it.